Financials data is unavailable for this security.
Cash flow in USDView more
In 2024, Solid Biosciences Inc increased its cash reserves by 8.36%, or 6.34m. Cash Flow from Financing totalled 122.44m or -- of revenues. In addition the company used 100.01m for operations while cash used for investing totalled 16.09m.
| Cash flow per share | -2.22 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 2.80 |
|---|---|
| Tangible book value per share | 2.80 |
More ▼
Balance sheet in USDView more
| Current ratio | 6.74 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0013 |
|---|---|
| Total debt/total capital | 0.0013 |
More ▼
